Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 4/20 | 1.00 |
| ▸ | AR | P10275 | 3/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 6/20 | 0.70 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.70 |
| ▸ | MEN1 | O00255 | 4/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.70 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.70 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2294866 | 1.00 | PGR (1.00) | PGRARCHRM1LMNANR3C1 | |
| SCHEMBL5020044 | 1.00 | PGR (1.00) | PGRARCHRM1LMNANR3C1 | |
| SCHEMBL16690685 | 1.00 | PGR (1.00) | PGRARCHRM1LMNANR3C1 | |
| Acetic Acid SCHEMBL25192781 | 0.98 | PGR (0.96) | PGRARCHRM1LMNANR3C1 | |
| Acetic Acid SCHEMBL28104035 | 0.97 | PGR (0.94) | PGRARCHRM1LMNANR3C1 | |
| Ethylene Glycol SCHEMBL28094936 | 0.96 | PGR (0.92) | PGRARCHRM1LMNANR3C1 | |
| SCHEMBL6690848 | 0.91 | PGR (0.83) | PGRARCHRM1LMNANR3C1 | |
| SCHEMBL6695320 | 0.90 | PGR (0.82) | PGRARCHRM1LMNANR3C1 | |
| Mechlorethamine SCHEMBL28097486 | 0.89 | PGR (0.79) | PGRARCHRM1LMNANR3C1 | |
| SCHEMBL11303204 | 0.88 | PGR (0.79) | PGRARCHRM1LMNANR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 30436 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746898-A2 | IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2026-05-27 | — | — | EP | claimed |
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| EP-3841097-B1 | 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER | BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) | 2026-05-20 | — | — | EP | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260109699-A1 | AZOLE DERIVATIVES AS SHP2 INHIBITORS | IRBM S.P.A. (IT) | 2026-04-23 | — | — | US | claimed |
| US-20260108476-A1 | 2,4 DNP and Prodrugs Thereof for Treatment of Cancer | MITOCHON PHARMACEUTICALS, INC. (US) | 2026-04-23 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4729519-A1 | CRYSTAL FORM OF ENPP1 INHIBITOR | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. (CN) | 2026-04-22 | — | — | EP | claimed |
| EP-4729063-A2 | TREATMENT OF CANCER USING COENZYME Q10 COMBINATION THERAPIES | BPGbio, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| US-12582672-B2 | Vanadium compositions and methods for treatment of cancer | THE BROAD INSTITUTE, INC. (US) | 2026-03-24 | — | — | US | claimed |
| EP-0472645-B1 | OSMOTIC DOSAGE FORM | ALZA CORPORATION (US) | 1993-07-14 | — | — | EP | claimed |
| US-5225192-A | Crosslinked, swellable polymer | VECTORPHARMA INTERNATIONAL S.P.A. (IT) | 1993-07-06 | — | — | US | claimed |
| EP-0336014-B1 | PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE, AND A METHOD FOR THEIR PREPARATION | VECTORPHARMA INTERNATIONAL S.p.A. (IT) | 1992-06-24 | — | — | EP | claimed |
| EP-0474374-A1 | Method for treatment of bone wasting diseases using a progestin | ORTHO PHARMACEUTICAL CORPORATION (US) | 1992-03-11 | — | — | EP | claimed |
| CN-1047974-A | Compositions and methods for effecting contraception | COHEN MICHAEL (NL) | 1990-12-26 | — | — | CN | claimed |
| EP-0364944-A1 | Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate | VECTORPHARMA INTERNATIONAL S.P.A. (IT) | 1990-04-25 | — | — | EP | claimed |
| EP-0155934-B1 | PHARMACEUTICAL COMPOSITIONS FOR TREATING ANDROGEN-RELATED DISORDERS IN HUMANS | Duke University (US) | 1989-12-06 | — | — | EP | claimed |
| CN-88101379-A | Methods and compositions for effecting contraception | — | 1988-10-05 | — | — | CN | claimed |
| EP-0010964-A1 | Ravidomycin, process of preparation and pharmaceutical compositions containing same | AYERST, MCKENNA AND HARRISON INC. (CA) | 1980-05-14 | — | — | EP | claimed |
| US-4177269-A | ANTITUMOR AGENTS | AKTIEBOLAGET LEO (SE) | 1979-12-04 | — | — | US | claimed |